Inflammation in Parkinson's disease: mechanisms and therapeutic implications

M Pajares, A I. Rojo, G Manda, L Boscá, A Cuadrado - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is a common neurodegenerative disorder primarily characterized
by the death of dopaminergic neurons that project from the substantia nigra pars compacta …

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

BG Trist, DJ Hare, KL Double - Aging cell, 2019 - Wiley Online Library
Parkinson's disease prevalence is rapidly increasing in an aging global population. With this
increase comes exponentially rising social and economic costs, emphasizing the immediate …

The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma

AI Ramirez, R de Hoz, E Salobrar-Garcia… - Frontiers in aging …, 2017 - frontiersin.org
Microglia, the immunocompetent cells of the central nervous system (CNS), act as
neuropathology sensors and are neuroprotective under physiological conditions. Microglia …

Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950

SE Corcoran, R Halai, MA Cooper - Pharmacological reviews, 2021 - ASPET
Activation of the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome
drives release of the proinflammatory cytokines interleukin (IL)-1 β and IL-18 and induces …

The reciprocal interactions between microglia and T cells in Parkinson's disease: a double-edged sword

Y Xu, Y Li, C Wang, T Han, H Liu, L Sun, J Hong… - Journal of …, 2023 - Springer
In Parkinson's disease (PD), neurotoxic microglia, Th1 cells, and Th17 cells are
overactivated. Overactivation of these immune cells exacerbates the disease process and …

Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson's disease

F Patricio, AA Morales-Andrade… - Frontiers in …, 2020 - frontiersin.org
The phytocannabinoids of Cannabis sativa L. have, since ancient times, been proposed as a
pharmacological alternative for treating various central nervous system (CNS) disorders …

Neuroinflammation and Parkinson's disease—From neurodegeneration to therapeutic opportunities

B Araújo, R Caridade-Silva, C Soares-Guedes… - Cells, 2022 - mdpi.com
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder
worldwide. Clinically, it is characterized by a progressive degeneration of dopaminergic …

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

P Troncoso-Escudero, A Parra, M Nassif… - Frontiers in …, 2018 - frontiersin.org
Neuroinflammation is one of the most important processes involved in the pathogenesis of
Parkinson's disease (PD). The current concept of neuroinflammation comprises an …

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges

J Han, V Chitu, ER Stanley, ZK Wszolek… - Cellular and Molecular …, 2022 - Springer
Microglia are specialized dynamic immune cells in the central nervous system (CNS) that
plays a crucial role in brain homeostasis and in disease states. Persistent …

A systematic review of minor phytocannabinoids with promising neuroprotective potential

NL Stone, AJ Murphy, TJ England… - British Journal of …, 2020 - Wiley Online Library
Embase and PubMed were systematically searched for articles addressing the
neuroprotective properties of phytocannabinoids, apart from cannabidiol and Δ9 …